Original Research
Accepted on 18 Feb 2026
Association Between GLP-1 Receptor Agonist Use and Substance Use Disorders Among Individuals with Type 2 Diabetes or Obesity: A Nested Case-Control Study in the All of Us Research Program
in Addictive Disorders